Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW

NCT06095362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Carcinoma
Surgery

Interventions

DRUG: Bevacizumab-IRDye800CW

Sponsor

University Medical Center Groningen

Collaborators

[object Object]